Efficacy of Cognitive Behavioral Therapy at Vestibular Migraine

ConditionCognitive Behavioral Therapy to Medical Treatment on Functional Ability of Patients With Vestibular Migraine

Trial statusNot yet recruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexAll

Age18-60

SponsorSohag University

About this trial

The management of vestibular migraine is multifaceted and includes both pharmacological and non-pharmacological approaches. Aim of work Evaluate the efficacy of adding Cognitive Behavioral Therapy (CBT) to standardized Medical treatment on improving functional ability of Vestibular Migraine.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Age: 18-60 years. Patients with a confirmed diagnosis of Vestibular Migraine according to ICHD-3 (Not better accounted by another vestibular disorder or another disease) Psychological state: Patients with stable general and psychological condition.

Disqualifiers

Age: below 18, above 60 years Other Vestibular Disorders as Ménière's disease, Benign Paroxysmal Positional Vertigo, Vestibular neuritis and Central neurological disorder Systemic or Other Causes Orthostatic hypotension Anxiety/panic disorders Drug-induced dizziness Psychological state: Patients with active psychiatric disorders requiring immediate intervention.

Trial design

Design model

Parallel

Treatments tested in this trial

•Group A: Patients will receive Medical treatment only: Beta-blockers (Propranolol) , Calcium channel blockers
Drug
Group A: Patients will receive Medical treatment only: beta blocker :20 mg twice daily ca channel blocker:5 mg once daily
Group B: Cognitive Behavioral Therapy (CBT) +Medical treatment
Drug
Structured CBT program consisting of 6-8 sessions over 8 weeks . Session 1: Psychoeducation about Vestibular Migraine Session 2: Progressive muscle relaxation and mini relaxation Session 3: Increasing pleasant activities and coping with fear Session 4: Cognitive Restructuring Session 5: Trigger management and skill review. Session 6: Impact of thoughts and feelings (stress management and calm statements) Session 7: Skill review and self -monitoring process Session 8: Summery and review (if needed)

Treatment groups

60 Participants

are divided into 2 treatment groups

Group A: Group A: Patients will receive Medical treatment onlyActive comparator 1 intervention

Group B: Group B: Cognitive Behavioral Therapy (CBT) +Medical treatmentActive comparator 1 intervention

Trial outcomes

Primary outcomes

improving in Functional Ability of patients with vestibular migraine

1-DHI score Dizziness Handicap Inventory (DHI) is a 25-item self-assessment scale used to evaluate the self-perceived handicapping effects imposed by dizziness. The total score ranges from 0 to 100, where 0 indicates no handicap and 100 indicates severe handicap.

Time frame

1-Baseline and at 3 months post-intervention

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Sohag University

Lead sponsor

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: